nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children
|
Anh, Dang Duc |
|
2012 |
30 |
S1 |
p. A114-A121 nvt p. |
artikel |
2 |
Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine
|
Breiman, Robert F. |
|
2012 |
30 |
S1 |
p. A24-A29 nvt p. |
artikel |
3 |
A systematic review of rotavirus strain diversity in India, Bangladesh, and Pakistan
|
Miles, Melody G. |
|
2012 |
30 |
S1 |
p. A131-A139 nvt p. |
artikel |
4 |
Characterisation of a G9P[8] rotavirus strain identified during a gastroenteritis outbreak in Alice Springs, Australia post Rotarix™ vaccine introduction
|
Donato, C.M. |
|
2012 |
30 |
S1 |
p. A152-A158 nvt p. |
artikel |
5 |
Comparison of two clinical severity scoring systems in two multi-center, developing country rotavirus vaccine trials in Africa and Asia
|
Lewis, Kristen D.C. |
|
2012 |
30 |
S1 |
p. A159-A166 nvt p. |
artikel |
6 |
Distributional impact of rotavirus vaccination in 25 GAVI countries: Estimating disparities in benefits and cost-effectiveness
|
Rheingans, Richard |
|
2012 |
30 |
S1 |
p. A15-A23 nvt p. |
artikel |
7 |
Editorial Board/Aims and Scope
|
|
|
2012 |
30 |
S1 |
p. CO2- 1 p. |
artikel |
8 |
Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: A randomized, double-blind, placebo-controlled trial
|
Madhi, S.A. |
|
2012 |
30 |
S1 |
p. A44-A51 nvt p. |
artikel |
9 |
Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: A randomized, double-blind, placebo controlled trial
|
Cunliffe, Nigel A. |
|
2012 |
30 |
S1 |
p. A36-A43 nvt p. |
artikel |
10 |
Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya
|
Feikin, Daniel R. |
|
2012 |
30 |
S1 |
p. A52-A60 nvt p. |
artikel |
11 |
Efficacy of the oral pentavalent rotavirus vaccine in Mali
|
Sow, Samba O. |
|
2012 |
30 |
S1 |
p. A71-A78 nvt p. |
artikel |
12 |
Five-year cohort study on the burden of hospitalisation for acute diarrhoeal disease in African HIV-infected and HIV-uninfected children: Potential benefits of rotavirus vaccine
|
Groome, Michelle J. |
|
2012 |
30 |
S1 |
p. A173-A178 nvt p. |
artikel |
13 |
Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam
|
Shin, Sunheang |
|
2012 |
30 |
S1 |
p. A106-A113 nvt p. |
artikel |
14 |
Immunogenicity of the pentavalent rotavirus vaccine in African infants
|
Armah, George E. |
|
2012 |
30 |
S1 |
p. A86-A93 nvt p. |
artikel |
15 |
Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines
|
Patel, Manish |
|
2012 |
30 |
S1 |
p. A30-A35 nvt p. |
artikel |
16 |
Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in Bangladesh
|
Feller, Andrea J. |
|
2012 |
30 |
S1 |
p. A101-A105 nvt p. |
artikel |
17 |
Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in Bangladesh
|
Zaman, K. |
|
2012 |
30 |
S1 |
p. A94-A100 nvt p. |
artikel |
18 |
Molecular characterization of rotavirus strains detected during a clinical trial of a human rotavirus vaccine in Blantyre, Malawi
|
Nakagomi, Toyoko |
|
2012 |
30 |
S1 |
p. A140-A151 nvt p. |
artikel |
19 |
Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011–2030
|
Atherly, Deborah E. |
|
2012 |
30 |
S1 |
p. A7-A14 nvt p. |
artikel |
20 |
Research priorities regarding rotavirus vaccine and intussusception: A meeting summary
|
Tate, Jacqueline E. |
|
2012 |
30 |
S1 |
p. A179-A184 nvt p. |
artikel |
21 |
Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: Benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines
|
Lloyd-Johnsen, C. |
|
2012 |
30 |
S1 |
p. A190-A195 nvt p. |
artikel |
22 |
Rotavirus vaccines for children in developing countries: Understanding the science, maximizing the impact, and sustaining the effort
|
Neuzil, Kathleen M. |
|
2012 |
30 |
S1 |
p. A1-A2 nvt p. |
artikel |
23 |
Rotavirus vaccines in developing countries: The potential impact, implementation challenges, and remaining questions
|
Cherian, Thomas |
|
2012 |
30 |
S1 |
p. A3-A6 nvt p. |
artikel |
24 |
Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq®, in Kenya, including among HIV-infected and HIV-exposed infants
|
Laserson, Kayla F. |
|
2012 |
30 |
S1 |
p. A61-A70 nvt p. |
artikel |
25 |
Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa
|
Tapia, Milagritos D. |
|
2012 |
30 |
S1 |
p. A79-A85 nvt p. |
artikel |
26 |
Severity of rotavirus gastroenteritis in Indian children requiring hospitalization
|
Sowmyanarayanan, Thuppal V. |
|
2012 |
30 |
S1 |
p. A167-A172 nvt p. |
artikel |
27 |
Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: Insights for understanding the impact of rotavirus vaccination programs
|
Bányai, Krisztián |
|
2012 |
30 |
S1 |
p. A122-A130 nvt p. |
artikel |
28 |
Workshop on intussusception in African countries – Meeting report
|
Steele, A. Duncan |
|
2012 |
30 |
S1 |
p. A185-A189 nvt p. |
artikel |